For instance, Zamarin and colleagues found that CTLA-4 expression was upregulated after NDV infection, while analysis of the immunological characterization of tumor lesions revealed significant elevation of effector T cells to Treg ratios and increased frequencies of activated immune cells following combinatorial treatment of NDV and CTLA-4 inhibitors [108]. The gene discussed is CTLA4; the disease is neoplasm.